Current FDA oversight of vaping industry is likely to have minimal impact

Current Food and Drug Administration (FDA) oversight of the vaping industry in the U.S. is likely to have minimal impact, suggests an analysis of the regulator's warning letters for marketing violations, published online in the journal Tobacco Control.
Current Food and Drug Administration (FDA) oversight of the vaping industry in the U.S. is likely to have minimal impact, suggests an analysis of the regulator’s warning letters for marketing violations, published online in the journal Tobacco Control.